Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Consensus Statement on Robotic Nipple Sparing Mastectomy Expert Panel
Ryu, Jai Min , Mok, Chi Wei , Toesca, Antonio , Lai, Hung‐Wen , Kuo, Wen‐Ling , Cheng, Fiona Tsui-Fen , Song, Seung Yong , Johnson, Jeffrey , Shin, Hyukjai , Park, Hyung Seok , Johnson, Jeffrey E , Cheng, Fiona Tsui-Fen

Mayo Clinic

Journal of Breast Cancer | May 19, 2025 | Volume: 28 | Issue: 3 | Pages: 180

10.4048/jbc.2025.0030 | PMID 40432351 Get It

0797 Severe Obstructive Sleep Apnea Treated with Oral Appliance Therapy in Elderly Adults: A Cohort Study
Awadalla, Tanzeel Omer Elamin, Jagielski, Jack, Tripp, E. Gail, Johnson, Kimberly, Vadiyala, Mounika Reddy , Karnakoti, Snigdha , Herberts, Michelle , Westermeyer, Eliza Thompson, Giri, Subha , Escalante, Patricio , Tripp, Ellery, Arias, Pedro

Mayo Clinic

SLEEP | May 19, 2025 | Volume: 48 | Issue: Supplement_1 | Pages: A345-A345

10.1093/sleep/zsaf090.0797 Get It

Abstract Introduction Emerging evidence suggests that positive airway pressure (PAP) treatment for moderate-to-severe obstructive sleep apnea (OSA) in elderly patients does not improve daytime sleepiness, or quality of life outcomes, despite improving apnea-hypopnea index (AHI). While oral appliance therapy (OAT) is known to be an effective treatment for mild-to-moderate OSA, its efficacy in treatment of elderly patients with severe OSA is unknown. Methods Retrospective chart review of patients ≥ 65 years old with diagnosis of OSA, treated with OAT, who underwent subsequent follow-up sleep testing and clinical assessments, including Epworth Sleepiness Scale (ESS), a measure of daytime sleepiness. Results We studied 66 elderly patients with OSA (31 women, 35 men), including 58 with mild-to-moderate OSA (AHI < 30) and 8 with severe OSA (AHI ≥ 30) treated with OAT. At baseline, patients with mild-to-moderate OSA had a median AHI of 11.6 compared to 41.3 in patients with severe OSA (p < 0.0001). There was no difference in ESS score between patients with mild-to-moderate OSA (median ESS = 8; IQR = 4-12) and severe OSA (median ESS = 6; IQR = 3-9). Following their OSA diagnosis, OAT was offered due to PAP intolerance (n = 32), patient preference (n = 28), or as an alternative treatment option (n = 4). After initiation of OAT, 42 patients with mild-to-moderate and 7 with severe OSA underwent follow-up assessment with home sleep testing (n = 32), oximetry (n = 15), or polysomnography (n = 2). At follow-up assessment, ESS was decreased in patients with mild-to-moderate OSA (median ESS = 5; IQR = 3-8) and severe OSA (median ESS = 5; IQR = 3-7), indicating reduction in daytime sleepiness in response to OAT in both groups. Moreover, 50% of patients with mild-to-moderate OSA and 50% of severe OSA patients saw ≥ 50% reduction in AHI. Conclusion Our study findings suggest that treatment with OAT in mild-to-moderate and severe OSA is tolerable and effective in elderly patients who do not have contraindication for this treatment. OAT should be considered as an alternative treatment specifically for elderly adults with severe OSA not tolerating or improving with PAP therapy. Support (if any)
Educational Gaps and Suggestions for Change for Pediatric Transplant Fellowship Training Based on Fellow Survey Responses
Gallegos, Flora R. , McCulloch, Mignon , Nair, Nikhil , Hinton, Jared , Twombley, Katherine , Johnson, Jonathan N. , Bonham, Clark A. , Preka, Evgenia , Bhaskar, Anchal, Hu, Jieji , Marks, Stephen D. , Esquivel, Carlos O. , Raina, Rupesh , Gallegos, Flora R , Hinton, Jared , Bartosh, Sharon , Hu, Jieji , Twombley, Katherine E , McCulloch, Mignon , Pape, Lars , Oh, Jun Seok , Bartosh, Sharon , Bhaskar, Anchal

Mayo Clinic

Pediatric Transplantation | May 19, 2025 | Volume: 29 | Issue: 4 | Pages: No page available

10.1111/petr.70105 | PMID 40384447 Get It

ABSTRACT Background Advancements in organ transplant technology are pushing global transplant capabilities to new heights. However, challenges persist in pediatric surgical and medical transplant fellowship training, primarily due to a limited number of adequate training programs and gaps in education. Addressing these gaps is essential for improving patient outcomes and advancing the field of pediatric transplantation. Methods An international survey was distributed to 416 pediatric transplant fellows via multiple global transplant associations. The 29‐question survey, available in English and Spanish, assessed current clinical knowledge, training satisfaction, and preferred learning formats. The survey received responses from 237 pediatric transplant fellows. Results One of the key findings was that respondents felt most confident in their pre‐transplantation clinical knowledge. About 75.5% of fellows reported being extremely or very aware of pre‐transplant workups and assessments. However, significant gaps were identified in other areas of training. Notably, 24% of respondents felt extremely knowledgeable about the side effects of immunosuppression, and only 22.8% were very confident in managing acute rejection. Fellows expressed strong interest in dynamic educational formats, particularly clinical case discussions (88.8%). Preferred methods to enhance training included continuing medical education (64.6%), hands‐on workshops, and support for transition protocols and psychosocial counseling. Conclusion This global survey highlights critical educational gaps in pediatric transplant fellowship training and identifies preferred learning methods among fellows. Targeted improvements such as standardized curricula, case‐based learning, interdisciplinary collaboration, and accessible continuing education are essential to enhance training. These strategies will ensure that future transplant professionals are well‐equipped to deliver high‐quality care across diverse healthcare settings.
Engaging Community Reviewers: The Geriatric Emergency Care Applied Research (2.0)—Advancing Dementia Care Network Approach
Gifford, Angela , McClellan, Chelsea, Daven, Morgan, Foster, Beverly, Gil, Heidi, Johnson, Jerry , Jobe, Deborah, Carpenter, Christopher R. , Hwang, Ula , Carpenter, Christopher R , Hwang, Ula , Shah, Manish N , McClellan, Chelsea, Ellenbogen, Michael I. , Foster, Beverly, Dresden, Scott M. , Gilmore‐Bykovskyi, Andrea L , Shah, Manish N.

Mayo Clinic

Journal of the American Geriatrics Society | May 16, 2025 | Volume: 73 | Issue: 9 | Pages: 2678-2684

10.1111/jgs.19515 | PMID 40377497 Get It

ABSTRACTA core tenant of the Geriatric Emergency care Applied Research Network 2.0—Advancing Dementia Care (GEAR 2.0‐ADC) is the inclusion of community members during all stages of clinical research. As such, we deliberately integrated and supported patient and public involvement in the evaluation and selection of GEAR 2.0‐ADC Pilot Research Grants by developing and adapting traditional grant application review structures, with input from community members, to create the GEAR 2.0‐ADC Community Review Committee approach. Community members, including persons living with dementia, effectively participated in all three rounds of research grant application review and selection, complementing the traditional scientific review process. The structure and flexibility of the GEAR 2.0‐ADC Community Review Committee approach serve as a model for patient and public grant application review involvement with strong potential for applications across grant reviews in other medical specialties.
Artificial Intelligence-Derived Age as a Predictor of Cardiovascular Morbidity and Mortality in an Obstetric Population: Results From the SPEC-AI Nigeria Randomized Clinical Trial [ID 1565]
Rose, Carl H., Tobah, Yvonne S. Butler, Adedinsewo, Demilade , Tobah, Yvonne Butler , Johnson, Patrick W. , Noseworthy, Peter A. , Carter, Rickey E.

Mayo Clinic

Obstetrics & Gynecology | May 15, 2025 | Volume: 145 | Issue: 6S | Pages: 81S-81S

10.1097/aog.0000000000005918.091 Get It

INTRODUCTION: The SPEC-AI Nigeria trial (NCT05438576) was designed to use artificial intelligence (AI) to screen for pregnancy-related cardiomyopathy in the peripartum period. Using data from this study, we evaluated the utility of AI-predicted delta age (adjusted AI-predicted age − chronological age) as a surrogate for biological age. METHODS: We included 1,187 pregnant and postpartum women enrolled between August 2022 and September 2023 with follow-up through May 2024. Standard 12-lead electrocardiograms (ECGs) were recorded at study entry to generate AI age predictions. Artificial intelligence-predicted age was adjusted using estimated reference ranges obtained from a community-dwelling cohort of 25,144 individuals with AI-ECG age estimated and documented chronological age. Logistic and Cox-proportional hazards regression were used to examine associations with comorbid cardiovascular conditions and maternal mortality, respectively. RESULTS: Adjusted AI-predicted age was significantly higher among women with any cardiovascular condition, peripartum cardiomyopathy, or who died within 18 months (7, 14, and 23 years older, respectively) compared to those without these conditions who had values similar to the normal reference ranges (adjusted AI-predicted age difference less than 1 year). Artificial intelligence-predicted delta age greater than the 75th percentile was associated with an odds ratio (OR) of 2.06 for any cardiovascular condition, OR of 4.98 for left ventricular systolic dysfunction, and a hazard ratio of 32.81 for all-cause mortality; all values of P<.001. CONCLUSIONS/IMPLICATIONS: Artificial intelligence-ECG-derived biological age appears to be a potentially useful measure of cardiovascular health status and risk among pregnant and postpartum women. However, its role in monitoring maternal health requires further exploration.
Psychiatric Prognosis Following Index Suicide Attempts in Early Adolescents
Bommersbach, Tanner J. , Johnson, Grace , Bostwick, John , McKean, Alastair J. , Bostwick, J Michael, McKean, Alastair J S, Johnson, Grace, Pazdernik, Vanessa

Mayo Clinic

JAMA Psychiatry | May 14, 2025 | Volume: 82 | Issue: 7 | Pages: 728

10.1001/jamapsychiatry.2025.0673 | PMID 40366679 Get It

ImportanceThe rates of suicide and suicide attempts are rising precipitously among early adolescents aged 10 to 14 years in the US. While suicide attempts in this age group are more common and associated with lower lethality than in older age groups, very little is known about these individuals’ long-term social and psychiatric outcomes.ObjectivesTo examine the adult outcomes of individuals making index suicide attempts that came to medical attention between the ages of 10 and 14 years.Design, Setting, and ParticipantsThis population-based cohort constitutes a subsample (n = 164) of a previously reported retrospective-prospective study examining individuals who made index suicide attempts during a 22-year period (1986-2007) in Olmsted County, Minnesota.Main Outcomes and MeasuresTo collect outcome measures, the medical records of all individuals were queried until March 31, 2023, comprising up to 36 years of follow-up data after the index attempt. Measures included current social, psychiatric, and mortality outcomes as well as lifetime measures of psychiatric hospitalizations and repeat suicide attempts. K-means clustering generated adult groupings based on aggregates of psychiatric hospitalizations and repeat attempts. Multivariable logistic regression identified index attempt factors associated with poor adult outcomes.ResultsOf 164 individuals aged 10 to 14 years who made index attempts (128 [78.0%] female; mean [SD] age at index attempt, 13.7 [1.1] years), 3 (1.8%) died on the index attempt. In the follow-up period, no individuals died by suicide. K-means clustering generated a 2-group solution reflecting low (120 [80%]) and high (30 [20%]) rates of adult psychopathology. While a minority of the sample belonged to the high-rate group, characterized by multiple repeat attempts and hospitalizations, the majority had favorable social indicators and fewer reattempts and hospitalizations. Poor adult outcomes were associated with being male (odds ratio, 2.44; 95% CI, 1.00-5.80; P = .04) and having a psychiatric diagnosis prior to the index attempt (odds ratio, 3.27; 95% CI, 1.42-8.07; P = .007).Conclusions and RelevanceIn this sample of early adolescents with index suicide attempts followed into adulthood, all who died by suicide did so on the index attempt. While a small number of individuals went on to develop chronic severe psychopathology, the majority demonstrated little evidence of long-term impairment. Given this discrepancy, future studies should focus on using risk stratification after index attempts to direct postvention resources toward adolescents more susceptible to poor outcomes.
Novel Correlations Between Exhaled Breath Volatile Organic Compounds (VOCs) and Lung Function in Ultramarathon Runners: Insights from the 2019 Ultra-Trail du Month Blanc
Chou, Hung‐Hsueh , Craster, Amy, Arthur, Keith, Boyle, B., Allsworth, Max, Kelley, E.F., Schwartz, Jesse C., Ziegler, Briana, Johnson, Kenneth A. , Robach, Paul , Basset, P., Johnson, Bruce D. , Khider, A., Davies, H., Chou, H., Arthur, K., Stewart, Glenn M. , Wheatley, C.M., Fermoyle, Caitlin C. , Johnson, K., Khider, A.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A6817-A6817

10.1164/ajrccm.2025.211.abstracts.a6817 Get It

Abstract Rationale: Volatile organic compounds (VOCs) in exhaled breath change significantly after ultramarathons and could help monitor athletes’ physiological status to optimize training. While VOCs can reflect metabolic changes, the connection between VOCs and clinical blood and respiratory data remains unknown. In this study, we investigated how breath VOCs are linked to clinical variables that reflect the cardiovascular and respiratory system. Methods: Correlation analysis was performed between respiratory data collected in pre- and post-race samples from 24 runners who participated in the 2019 Ultra-Trail du Mont Blanc (UTMB®) ultra-marathon. Correlation analysis was then performed between these clinical data and previously published breath VOC data collected from the same individuals. Results: Clinical data indicated a slight decrease in runner's lung function post-race. Interestingly, in post-race samples, respiratory parameters vital capacity (VC) and forced expiratory volume in one second (FEV1) formed a moderate positive correlation with 2,3-butanediol (r = 0.53, r = 0.63, respectively), a compound produced by bacterial metabolism. We hypothesize that production of 2,3-butanediol results from the effect of exhaustive exercise on the gut microbiome, which may provide protection to ameliorate lung injury. Additionally, a strengthened correlation from moderate (r = 0.5 – 0.7) to strong (r &gt; 0.7) between VC and FEV1 (r = 0.67 to r = 0.84), forced vital capacity (FVC) and maximal expiratory pressure (MEP) (r = 0.57 to r = 0.75), was observed from pre-race to post-race samples. Finally, FEV1 and MEP shifted from no correlation (r &lt; 0.5) in pre-race to a strong correlation (r = 0.73) in post-race. Conclusion: The strengthened correlation between respiratory data in post-race samples suggests that the gut microbiome, under the effect of exercise, may have an indirect impact on both lung function and respiratory muscle function changes. Our findings support the notion that there is an intricate relationship between exhaustive exercise, altered gut microbiome activity, and lung function, and together they can influence athlete performance.
Proteomics of CT Emphysema Subtypes in the General Population. The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
Guzman, Daniel E., Sun, Yifei , Bertoni, Alan, Johnson, W. Craig , Watson, Karol E., Hoffman, E.A., Dubin, Robert , Oelsner, Elizabeth C. , Laine, Andrew F. , Ortega, Victor E. , Oelsner, Elizabeth C , Pottinger, Tess D. , Post, Wendy S. , Allen, Norrina B. , Pankow, James S. , Manichaikul, Ani , Dubin, R., Deo, Rajat , Angelini, Elsa D. , Bowler, Russell P. , Ganz, Peter , Barr, R. Graham

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5009-A5009

10.1164/ajrccm.2025.211.abstracts.a5009 Get It

Abstract Chronic obstructive pulmonary disease (COPD) and pulmonary emphysema were the third-leading cause of death globally in 2019. Besides alpha-1 antitrypsin deficiency, emphysema lacks disease-modifying medications due to its heterogeneity and there remains a need to further investigate emphysema subtypes to advance its diagnosis and treatment. Recent unsupervised machine learning of the texture and anatomical location of emphysema on computed tomography (CT) images of the lung defined six quantitative CT emphysema subtypes uniquely associated with specific gene variants, environmental exposures, symptoms, physiology and clinical events. We aim to identify associations of plasma proteins with each CT emphysema subtype cross-sectionally in a multi-ethnic general population sample. MESA is a prospective cohort study that recruited 6,814 participants from six communities who self-identified as White, Black, Hispanic, or Asian race/ethnicity, ages 45-84 years old and free of clinical cardiovascular disease in 2000-02. The MESA Lung Study performed CT scans among 3,137 participants in 2010-12, which were labeled with previously described (PMID: 37268414) CT emphysema subtypes. Proteomics was assessed using SomaScan version 4.1 assay (7,596 plasma proteins). Linear regression models were adjusted for age, height, weight, sex, race, educational attainment, smoking status, pack years, urine cotinine level, body-mass index (BMI), estimated glomerular filtration rate (eGFR), CT scanner manufacturer and other CT emphysema subtypes. Results were adjusted to reflect a False Discovery Rate (FDR) p-value of less than 5% using the Benjamini-Hochberg method. Among 2,343 participants with both CT and proteomic data (mean age 69.5 years, 52.3% women, 23.7% with COPD), we identified statistically significant associations of proteins with the vanishing lung subtype (42 proteins; top hit Natural cytotoxicity triggering receptor 3 ligand 1, q = 2.9[asterisk]10-9), restrictive combined pulmonary fibrosis/emphysema (CPFE) subtype (11 proteins; top hit Integrin alpha-2/b1, q=1.0[asterisk]10-5), the combined bronchitis-apical emphysema subtype (9 proteins; top hit Desmoglein-2, q=8.8[asterisk]10-13), and the diffuse emphysema subtype (4 proteins; top hit Pulmonary surfactant-associated protein D, q=5.7[asterisk]10-3). No significant proteins were associated with the obstructive CPFE or senile subtypes after FDR correction. Most proteins were uniquely associated with one CT emphysema subtype, while a few proteins were associated with more than one subtype. This study identified specific proteins for different CT emphysema subtypes, many of which have been related less specifically to emphysema, including pulmonary surfactant production, anti-inflammatory pathways, and mitochondrial deregulation, amongst others. Validation of these proteomic associations can provide insight into further pathway assessment, clinical biomarker discovery, and targeted prevention of emphysema in the general population.
Quantification of Lung Water by Thoracic CT in Heart Failure Patients
Vungarala, Soumya , Wentz, Robert J., Olson, Lyle J. , Johnson, Bruce D.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4313-A4313

10.1164/ajrccm.2025.211.abstracts.a4313 Get It

Abstract Rationale: Heart failure (HF) is often characterized by elevated left ventricular filling pressures (LVFP) and pulmonary congestion. However, LVFP may not always predict congestion. Pulmonary congestion can be quantified by computed tomography (CT) imaging. We hypothesized that extravascular lung water quantified by CT may differ in HF groups such as HF with preserved ejection fraction (HFpEF) vs HF with reduced ejection fraction (HFrEF), inpatients with acute decompensated heart failure (ADHF) vs stable and this would be related to echocardiography (echo) derived estimates of LVFP. Methods: We enrolled and studied 83 patients with HF who were either admitted or had a clinic visit at Mayo Clinic, Rochester, MN from May 2018 through March 2019. All subjects underwent comprehensive echo and supine thoracic CT scans. CT lung fluid was quantified and reported as proportion (%) of total lung volume. CT attenuation in lung tissue was also measured. LVFP was evaluated according to standardized echo diagnostic algorithms. Patients were stratified based on clinical diagnosis of HF as inpatients with HFpEF (n=26, 75.6±8.5yrs, M=50%, BMI=36.2±8.9kg/m2) inpatients with HFrEF (n=33, 75.6±14yrs, M=79%, BMI=31.1±9.1kg/m2), inpatients with ADHF (n=14, 72.6±14.5yrs, m=64.2%, BMI= 32.2±7.6Kg/m2) and stable outpatient HF controls (n=10, 65±13 yrs, m=90%, BMI= 29.5±5.2Kg/m2). All four groups were compared using one-way ANOVA followed by a post-hoc analysis. A correlation between lung fluid % and LVFP was performed using Spearman's correlation test. Results: When HF groups were compared according to CT % lung fluid, significant differences were found between HF groups (p=0.004). Post-hoc analysis revealed a significant difference in % lung fluid as HFrEF group had higher mean value in % lung fluid compared to HF control group (p=0.004). Similarly, ADHF group had higher mean % lung fluid compared to HF control group (p= 0.007). However, we found no correlation between LVFP and % lung fluid. The rightward shift in CT attenuation for HFpEF, HFrEF, and ADHF subjects, as displayed in figure 1, suggests greater levels of % lung water in these subjects compared to controls. Conclusion: These data suggest that CT measures of lung water differ in subgroups of HF patients and may not correlate with LVFP.
Prevalence of Non-cystic Fibrosis Bronchiectatic Changes in Expiratory Central Airway Collapse
Funes‐Ferrada, Rodrigo , Valdes‐Camacho, Sofia , Abia-Trujillo, D., Fernández-Bussy, Sebastián , Johnson, Margaret M. , Barrios‐Ruiz, Alanna , Lee‐Mateus, Alejandra Yu , Vaca‐Cartagena, Bryan F. , Ibrahim, Mohamed

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A1974-A1974

10.1164/ajrccm.2025.211.abstracts.a1974 Get It

Abstract Background: Expiratory central airway collapse (ECAC) is defined by excessive inward bulging of either posterior tracheobronchial membrane or anterolateral cartilage. ECAC commonly coexists with COPD, asthma, GERD, and obstructive sleep apnea. ECAC association with bronchiectasis is yet to be documented. Common conditions leading to bronchiectasis are obstructive lung diseases predisposing to recurrent infections, cystic fibrosis, COPD, or idiopathic. This study aims to evaluate the occurrence of bronchiectasis in patients with ECAC as the primary outcome and the correlation between the severity of bronchiectasis and the severity of ECAC as a secondary outcome. Methods: A retrospective single-center study evaluated patients diagnosed with ECAC using dynamic bronchoscopy in Mayo Clinic, Florida, from June 2019 to December 2020. Radiologists analyzed dynamic, or non-contrast chest computed tomography (CT) scans to evaluate the presence of bronchiectatic changes and the prevalence of bronchiectasis in this population. Bronchiectatic changes were documented using the Brody scoring system which recorded the bronchiectasis size, extent and tree in bud appearance in individual lobes. The final score had a range from 0 to 72. The bronchiectasis scores for individual lung lobes were analyzed to interpret distribution of bronchiectasis in ECAC population. The combined bronchiectasis scores of severe ECAC and non-severe ECAC cohorts were compared to assess if severe ECAC had higher bronchiectatic involvement. Results: Out of the 166 patients diagnosed with ECAC through dynamic bronchoscopy, 133 patients (80.1%) presented bronchiectatic changes in their CT scans. Of the 59 patients with severe ECAC, 51 patients (86.4%) were diagnosed with bronchiectasis. Of the 107 patients with non-severe ECAC, 82 (76.6 %) had bronchiectasis. The mean bronchiectasis scores are greater in right and left lower lobes, followed by middle lobes. The median values between severe and non-severe ECAC were 3 and 3 respectively with a p value of 0.34. The inter quartile range was 9 in severe ECAC group and 6 in non-severe ECAC (graph 1). Discussion: The outcomes of this study showed a significant presence of bronchiectatic changes in the ECAC population, implying the importance of evaluating for other pathologies. It can signify a pathological process similar to other pathologies which predispose to recurrent infections except for cystic fibrosis, which has an upper lobe involvement. The correlation of severity between ECAC and bronchiectasis requires more studies with a larger cohort for significant outcomes.